Expression of checkpoint kinase 1 and polo-like kinase 1 and its clinicopathological significance in benign and malignant lesions of the stomach

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 10, 2010, Pages 1080-1084

  Yao, Hongliang ^a   Yang, Zhulin ^a   Li, Yangguo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Checkpoint kinase 1; Immunohistochemistry; Polo like kinase 1; Stomach diseases; Stomach neoplasms

Indexed keywords

CELL CYCLE PROTEIN; CHECKPOINT KINASE 1; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; FEMALE; GASTRITIS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; CELL CYCLE PROTEINS; FEMALE; GASTRITIS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649896033     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.10.008     Document Type: Article

References (17)

1. Bartek J, Lukas J. Chk 1 and chk 2 kinases in checkpoint control and cancer [J]. Cancer Cell, 2003, 3(5) :421-429.
2. Senderowicz A M. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms [J]. Cancer Chemother Pharmacol, 2003, 52 (suppl) : s61-s73.
3. 2 arrest can occur independently of chk 1 , chk 2 or MAPKAPK2[ J]. Cell Cycle, 2008, 7(11): 1668-1677.
4. Verlinden L, Vande Bempt I, Eelen G, et al, The E2Fregulated gene chk 1 is highly expressed in triple - negative estrogen receptor/progesterone receptor/ HER -2 breast carcinomas[ J]. Cancer Res, 2007,67 (14) :6574-6581.
5. Matsumoto K , Nagahara T , Okano J , et al. The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal - regulated and checkpoint kinases [J]. Oncol Rep , 2008, 20(4) : 863-872.
6. Menoyo A. Alazzouzi H. Espin E. Armengol M. Yamamoto H. Schwartz S. Jr. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability Cancer Research 2001 61 21 7727-7730 [6] Menoyo O A , Alazzouzi H , Espin E , et al. Somatic mutations in the DNA damage - response genes ATR and CHK1 in sporadic stomach tumors with microstatellite instability [J]Cancer Res, 2001 , 61(21) :7727-7730. (Pubitemid 33049356)
7. MA Quanfu , HUANG Xiaoyuan , GAO Qinglei , et al. Expression of CHK1/2 and plk 1 protein in endometrial carcinoma [ J ] . Cancer Research on Prevention and Treatment, 2008, 35(6) :424-426.
8. Malumbres M , Barbacid M. Cell cycle kinases in cancer [J]. Curr Opin Genet Dev , 2007 , 17(1) :60-65.
9. Martin B T , Strebhardt K. Polo-like kinase 1 : and regulator of transcriptional control [J]. Cell Cycle , 2006 , 5 (24) :2881-2885.
10. Wang X Q , Zhu Y Q , Luis K S , et al. Aberrant polo-like kinasel-cdc25 A pathway in metastatic hepatocellular carcinoma [J] . Clin Cancer Res, 2008, 14 (21) : 6813-6820.
11. Rizki A, Mott J D, Bissell M J. Polo-like kinase 1 is involved in invasion through extracellular matrix [J]. Cancer Res, 2007,67(23) :1106-1110.
12. Denkert C , Thoma A , Niesporek S , et al. Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepthelial neoplasia - association with increased expression of polo-like kinase-1 [J]. Prostate, 2007, 67 (4) :361-369.
13. Kanaji S, Saito H, Tsujitani S, et al. Expression of pololike kinase 1 ( PLK 1) protein predicts the survival of patients with gastric carcinoma [J]. Oncology, 2006, 70(2) : 126-133.
14. Weichert W. Schmidt M. Jacob J. Gekeler V. Langrehr J. Neuhaus P. Bahra M. Denkert C. Dietel M. Kristiansen G. Overexpression of polo-like kinase 1 is a common and early event in pancreatic cancer Pancreatology 2005 5 2 3 259-265 DOI 10.1159/000085280 [14] Weichen W , Schmidt M , Jacob J , et al. Overexpression of polo-like kinase 1 is a common and early event in pancreatic cancer[J]. Pancreatology , 2005, 5 (2/3) :259-269. (Pubitemid 40754747)
15. Takai N , Hamanaka R , Yoshimatsu J , et al. Polo-like kinases ( PLKs ) and cancer [J]. Oncogene, 2005 , 24 (2) :287-291.
16. Takahashi T , Sano B , Nagata T , et al. Polo - like kinase 1 ( PLK 1) is overexpressed in primary colorectal cancers [J]. Cancer Sci, 2003, 94(2) :148-152.
17. Yamamoto Y , Matsuyama H , Kawauchi S , et al. Overexpression of polo-like kinase 1 ( PLK1 ) and chromosomal instability in bladder cancer [J]. Oncology , 2006, 70(3) : 231-237.